TORONTO, July 18, 2014 /CNW/ - Marc Wayne, President and CEO of Bedrocan
Canada, Inc. will be featured in a one-on-one interview with markets
commentator Andrew McCreath today at 4:30 pm ET. Mr. McCreath is the
host of Weekly on the Business News Network (BNN). The feature will
also be archived for viewing on the BNN.ca web page for Weekly with
The interview will cover the evolution of the use of medicinal cannabis
in Canada, and highlight Bedrocan's unique strengths in the market, as
the company prepares for its upcoming public listing on the TSX Venture
Exchange via a Qualifying Transaction with POCML 2 Inc. (TSX-V:PCC.P).
Mr. Wayne will discuss Bedrocan's experience of more than 10 years as a
producer of government-approved medicinal cannabis in Europe and
Canada, and the only source of legally-exported cannabis in the world.
He will also cover Bedrocan's focus on cannabis research and product
innovation, and the need to provide patients and health care
professionals with the highest-quality standardized
pharmaceutical-grade cannabis, for the symptomatic management of a
variety of serious health conditions.
Bedrocan Canada is affiliated and partnered with "Bedrocan BV" of the
Netherlands. "Bedrocan Canada Inc", is a Canadian company with
extensive knowledge and experience in the use of cannabis and
cannabinoids in clinical practice.
For more than 10 years, Bedrocan has worked with universities, industry,
government, and NGO partners in Europe and around the world to conduct
the genetic, botanical, chemical, and social research necessary to help
cannabis meet the regulatory demands of modern medicine. Bedrocan has
been licensed since December, 2013, to supply medicinal cannabis to
meet the needs of patients registered with Health Canada to receive
cannabis as medicine.
Image with caption: "Bedrocan Canada Inc. (CNW Group/Bedrocan Canada Inc.)". Image available at: http://photos.newswire.ca/images/download/20140718_C8219_PHOTO_EN_42191.jpg
SOURCE: Bedrocan Canada Inc.
For further information: